Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.8300
-0.0035 (-0.42%)
At close: Aug 13, 2025, 4:00 PM
0.8110
-0.0190 (-2.29%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
Lexaria Bioscience Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lexaria Bioscience stock has a target of 4.00, which predicts a 381.93% increase from the current stock price of 0.83.
Price Target: $4.00 (+381.93%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Lexaria Bioscience is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $4 | Strong Buy | Maintains | $5 → $4 | +381.93% | Jul 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $5 | Strong Buy | Maintains | $7 → $5 | +502.41% | Jul 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +743.37% | Jan 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,104.82% | Dec 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,104.82% | Nov 25, 2024 |
Financial Forecast
Revenue This Year
644.64K
from 464.28K
Increased by 38.85%
Revenue Next Year
800.19K
from 644.64K
Increased by 24.13%
EPS This Year
-0.64
from -0.47
EPS Next Year
-0.55
from -0.64
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 741,300 | 1.2M | 1.5M | |||
| Avg | 644,640 | 800,190 | 1.4M | |||
| Low | 546,840 | 392,000 | 1.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 59.7% | 90.3% | 84.1% | |||
| Avg | 38.8% | 24.1% | 78.8% | |||
| Low | 17.8% | -39.2% | 71.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.61 | -0.47 | -0.40 |
| Avg | -0.64 | -0.55 | -0.79 |
| Low | -0.66 | -0.67 | -1.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.